Effectiveness of monoclonal antibody therapy for COVID-19 patients using a risk scoring system.
Mutoh Y, Umemura T, Ota A, Okuda K, Moriya R, Tago M, Soejima K, Noguchi Y, Bando T, Ota S, Sato T, Hirota S, Hagimoto S, Takei R, Sasano H, Yamano Y, Kataoka K, Yokoyama T, Matsuda T, Kimura T, Ichihara T, Kondoh Y.
Mutoh Y, et al. Among authors: ota s, ota a.
J Infect Chemother. 2022 Feb;28(2):352-355. doi: 10.1016/j.jiac.2021.11.022. Epub 2021 Nov 30.
J Infect Chemother. 2022.
PMID: 34863647
Free PMC article.